APR 20, 2021 11:00 AM PDT

Microbial Identification and Confirmation using the Bruker MALDI Biotyper®: The Contract Laboratory Perspective

Sponsored by: Bruker Daltonics
C.E. Credits: P.A.C.E. CE Florida CE
Speaker

Abstract
Date:  April 20, 2021
Time: 11:00am (PST),  2:00pm (EST)
 
Identification and confirmation of microbial isolates is crucial in the analysis workflow, providing decision-makers the information required to release or hold products. Despite the difficulties in establishing a coherent definition for bacterial species and the long time-to-results, phenotypic and biochemical tests are still widely used and recognized. MALDI-TOF mass spectrometry has significantly changed the identification procedure and has to be extensively validated following AOAC and ISO 16140-6 guidelines. The Bruker MALDI Biotyper® is now regarded as a reliable and accurate alternative to quickly identify or routinely confirm systematic perspectives. Contract laboratories are beginning to adopt the Bruker MALDI Biotyper® as an efficient and effective alternative for identification and confirmation analysis in a routine laboratory setting.
 
Learning Objectives
  • Understand the perspective of contract laboratories and their role in routine testing, identification and confirmation of microorganisms.
  • Describe the process for validation of the MALDI-TOF and why this is necessary.
  • Explain how MALDI-TOF technology can improve the characterization and confirmation of microbiology isolates.
  • List the advantages of the Bruker MALDI Biotyper over the traditional identification methods such as biochemicals and molecular.
 
Not for use in clinical diagnostic procedures.
Please contact your local representative for availability in your country.
 
Webinars will be available for unlimited on-demand viewing after live event.
 
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

Show Resources
You May Also Like
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
MAR 16, 2022 8:00 AM PDT
C.E. CREDITS
MAR 16, 2022 8:00 AM PDT
Date: March 16, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CET) Handling of potent and/or hazardous substances is commonplace in sev.....
DEC 09, 2021 11:00 AM PST
C.E. CREDITS
DEC 09, 2021 11:00 AM PST
Date: December 09, 2021 Time: 11:00am (PDT), 2:00pm (EDT) The burden of antimicrobial resistance (AMR) has been acknowledged worldwide by leading health institutes. Besides the need for new...
MAR 23, 2022 11:00 AM PDT
MAR 23, 2022 11:00 AM PDT
Date: March 23, 2021 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEDT) In this presentation, Dr. Middleton will review the development and deployment of large-scale saliva-based COVID-19 test...
JAN 13, 2022 9:00 AM PST
C.E. CREDITS
JAN 13, 2022 9:00 AM PST
Date: January 13, 2022 Time: 09:00am (PST), 12:00pm (EST) Recently, the Infectious Disease Society of America released guidance on how to approach treatment of infections caused by multidrug...
FEB 24, 2022 10:00 AM PST
C.E. CREDITS
FEB 24, 2022 10:00 AM PST
Date: February 24, 2021 Time: 10:00am (PST), 1:00pm (EST) One of the largest global public health crises is the rise of antimicrobial-resistant infections. Globally, over 700,000 people die...
Loading Comments...
Show Resources